Cuomo Francesca, Altucci Lucia, Cobellis Gilda
Department of Precision Medicine, University of Campania "L. Vanvitelli", via L. De Crecchio, 7, 80138 Naples, Italy.
Cancers (Basel). 2019 Sep 29;11(10):1465. doi: 10.3390/cancers11101465.
Autophagy is a highly conserved catabolic and energy-generating process that facilitates the degradation of damaged organelles or intracellular components, providing cells with components for the synthesis of new ones. Autophagy acts as a quality control system, and has a pro-survival role. The imbalance of this process is associated with apoptosis, which is a "positive" and desired biological choice in some circumstances. Autophagy dysfunction is associated with several diseases, including neurodegenerative disorders, cardiomyopathy, diabetes, liver disease, autoimmune diseases, and cancer. Here, we provide an overview of the regulatory mechanisms underlying autophagy, with a particular focus on cancer and the autophagy-targeting drugs currently approved for use in the treatment of solid and non-solid malignancies.
自噬是一种高度保守的分解代谢和能量生成过程,它有助于降解受损的细胞器或细胞内成分,为细胞提供合成新成分的原料。自噬起着质量控制系统的作用,具有促生存作用。该过程的失衡与细胞凋亡相关,而细胞凋亡在某些情况下是一种“积极”且理想的生物学选择。自噬功能障碍与多种疾病相关,包括神经退行性疾病、心肌病、糖尿病、肝病、自身免疫性疾病和癌症。在此,我们概述自噬的调控机制,特别关注癌症以及目前已获批用于治疗实体和非实体恶性肿瘤的自噬靶向药物。